Recent research from Memorial Sloan Kettering Cancer Center (MSK) sheds light on the complex relationship between aging and cancer risk. While age is generally considered the primary risk factor for cancer due to accumulated genetic mutations, this study reveals that advanced age can also provide a protective effect against certain cancers.

The study, published in Nature, focused on a mouse model of lung adenocarcinoma. Researchers discovered that as mice age, they produce more of a protein called NUPR1, which causes cells to function as if they are iron deficient, despite having higher iron levels. This iron deficiency-like state reduces the cells' ability to regenerate, subsequently lowering the risk of tumor development in older mice.

Xueqian Zhuang, the study's first author, explains, "Aging cells lose their capacity for renewal and therefore for the runaway growth that happens in cancer." This finding helps explain why cancer incidence rates begin to decline after peaking around age 70-75.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

The research has two significant implications. First, it highlights the crucial role of iron metabolism in cellular regeneration, suggesting that therapies targeting iron metabolism may be more effective in younger patients. Second, it emphasizes the importance of early cancer prevention efforts, particularly during the period when most cancers initiate.

Interestingly, the study found that the age-related protective effect could be reversed by administering additional iron or reducing NUPR1 levels in older mice. While this discovery may have potential applications in regenerative medicine, it also underscores the delicate balance between tissue regeneration and cancer risk.

The findings also have implications for cancer treatments based on ferroptosis, an iron-dependent form of cell death. The research suggests that older cells are more resistant to ferroptosis due to their iron deficiency-like state, indicating that such treatments may be less effective in older patients.

Tuomas Tammela, the study's senior author, concludes that these findings emphasize the critical importance of cancer prevention efforts in younger individuals, as early-life events may have a more significant impact on cancer risk than previously thought.